ArticleAntimicrobial agents and chemotherapy2026
Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".
Agnès B Jousset, Delphine Girlich, Saoussen Oueslati, Aurélien Birer, Anne Delaval, Caroline Guyot, Ines Rezzoug, Cécile Emeraud, Thierry Naas, Rémy A Bonnin and 1 more
Abstract read
In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Agnès B JoussetUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.ORCID 0000-0002-8223-2213 Delphine GirlichUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
Saoussen OueslatiUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
Aurélien BirerFrench Associated National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre & Clermont-Ferrand, France.
Anne DelavalService de Bactériologie, Groupe Hospitalier Intercommunal du Raincy-Montfermeil, Montfermeil, France.
Caroline GuyotService de Bactériologie, Groupe Hospitalier Intercommunal du Raincy-Montfermeil, Montfermeil, France.
Ines RezzougUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.ORCID 0009-0006-9484-7932 Cécile EmeraudUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.ORCID 0009-0006-3595-6434 Thierry NaasUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.ORCID 0000-0001-9937-9572 Rémy A BonninUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
Laurent DortetUniversité Paris-Saclay, Inserm, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.ORCID 0000-0001-6596-7384 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42340323
PMCPMC13435809
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390